Prospective Maternal Surveillance of SSA (Sjögren Syndrome A) Positive Pregnancies Using a Hand-held Fetal Heart Rate Monitor

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

700 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-03-31

Study Completion Date

2020-06-16

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of the research study "Heart Sounds at Home" is for pregnant SSA or SSA/SSB (Sjögren syndrome B) antibody positive mothers to use a Doppler fetal heart rate monitor to detect abnormal heart rates and rhythms in their babies before they are born.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Continuous Non-invasive Hemodynamic Monitoring in Early-onset Severe Preeclampsia: a Comparison of Echocardiography, Bioreactance, and Finger Cuff Measurements

NCT05299229

Pre-Eclampsia

COMPLETED

Fetal Heart Rate Variability and Fetal Growth Restriction

NCT04288037

Fetal Growth Retardation

UNKNOWN

Minimally-invasive Assessment of Cardiac Output in Severe Preeclampsia

NCT00465114

Preeclampsia

WITHDRAWN

Use of In-Home Non-Stress Monitoring Device for Fetal Monitoring: A Nonsignificant Risk (NSR) Device Study

NCT07223996

Pregnancy Fetal Monitoring

RECRUITING NA

Day to Day Variation in Fetal Heart Rate Variability

NCT04289350

Fetal Growth Retardation

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study will enroll mothers during week 16-19 of gestation and will ask the mothers to use a hand-held Doppler monitor to listen to the baby's heart rate and rhythm twice daily from about week 16 to week 26 of the pregnancy. Pregnant mothers will be asked to keep a log of the heart rates and will undergo a fetal echocardiogram every 2 weeks during their study participation. In addition to these procedures, the study team will collect the mother's medical and obstetrical histories. Should irregular heart rhythms be detected at home, the mother will contact the investigator to be evaluated. After the baby is delivered, the study team will collect information about the baby's birth and heart rhythm evaluation (electrocardiogram).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sjogren's Syndrome Neonatal Systemic Lupus Erythematosus Fetal Heart Block Complete

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Pregnant women with positive SSA or SSA and SSB antibodies
* Gestational age (GA) between 16 and 19 weeks
* No signs of antibody-mediated fetal cardiac disease on pre-enrollment echo

Exclusion Criteria

* Subjects who are more than 19 weeks gestation
* Subjects who have a fetus with an estimated fetal weight below the 10th percentile will also not be included

Minimum Eligible Age

18 Years

Maximum Eligible Age

50 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No